Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open Randomized Trial on the Efficacy of Gonadotropin-releasing Hormone Agonist Depot-Triptorelin- to Prevent Chemotherapy Induced Premature Ovarian Failure in Lymphoma Patients.

NCT01160315 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.

NCT NCT01160315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open Randomized Trial on the Efficacy of Gonadotropin-releasing Hormone Agonist Depot-Triptorelin- to Prevent Chemotherapy Induced Premature Ovarian Failure in Lymphoma Patients.
Lead sponsor
Erasme University Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2002
Completion date
October 31, 2015
Enrollment
118 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

alkylating agents, fertility preservation, lymphoma